This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
Brookdale Senior Living (BKD) is showing signs of breaking its trend lower on increasing investor optimism. Activist investors have penned an open letter discussing how the value of BKD’s physical assets could lead to a doubling of its share price. Moreover, new management is in place to turnaround its operational efficiency. BKD’s share price has trended strongly lower the past few years, but looks attractively valued at its current distressed levels.
Real estate sectors finished the week mostly higher, powered by retreating US interest rates and solid economic data. REITs climbed a half-percent while homebuilders jumped more than 1%.
DDR.PRJ ACC DDR DDR.PRK LEN HTA DDR.PRA WELL BKD DDR.WI RVI.WI
Welltower Inc. (WELL - Free Report) has entered into a definitive agreement with its lessee and joint-venture (JV) partner — Brookdale Senior Living Inc. (BKD - Free Report) — for the comprehensive restructuring of the triple-net lease obligations on 63 communities of the latter. This move will significantly cut short Welltower’s association with Brookdale, as well as offer the former higher flexibility to form new JVs with preeminent senior housing operators.
HCN ABR WELL.PRI BKD CXP HCN.PRJ EXR HCN.PRI ABRN ABRN.CL WELL ABR.PRB ABR.PRC ABR.PRA
HCP Inc. (HCP - Free Report) is rumored to be selling the company’s 22 Brookdale-managed senior housing properties for $428 million to New York firm — Apollo Global Management LLC (APO - Free Report) — per a Bloomberg news. Earlier this June, the company announced that it has entered into definitive deals for selling those 22 properties, having 2,781 units, to an institutional investor. This healthcare REIT has been selling several of its senior housing assets in a bid to improve the quality of the company’s senior housing portfolio, strengthen balance sheet and lower the Brookdale Senior Living Inc.
PLD APO.PRB HFC APO.PRA HCP BKD APO EXR
HCP Inc. (HCP - Free Report) has undertaken portfolio-repositioning measures in a bid to improve the quality of its senior housing portfolio and lower the concentration of Brookdale Senior Living Inc. Earlier in this month, HCP provided an update about such efforts and it seems right on track to achieve its target. In fact, over time, with diligent measures, the company aims at having more than half of its business comprising specialty office segments of medical office and life science, and lower senior housing concentration to around 40%.
LHO TRNO.PRA ABR HCP BKD ABRN TRNO ABRN.CL LHO.PRG LHO.PRJ ABR.PRB ABR.PRC LHO.PRI ABR.PRA LHO.PRH
Investors in Brookdale Senior Living Inc. (BKD - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Jun 15, 2018 $7.00 Put had some of the highest implied volatility of all equity options today.
HCP Inc. (HCP - Free Report) has undertaken strategic portfolio-repositioning measures in a bid to improve the quality of its senior housing portfolio and lower the Brookdale Senior Living Inc. operator concentration. The company, recently, provided an update about such efforts and it seems right on track to achieve its target. Particularly, HCP has reaped $332 million of proceeds through completion of the disposition of its residual investment in the RIDEA II senior housing joint venture (JV) to an investor group led by Columbia Pacific Advisors, LLC.
PLD HCP BKD EXR
A month has gone by since the last earnings report for HCP, Inc. (HCP - Free Report) . Shares have added about 1.9% in that time frame.
Glenview Capital Management’s 13F portfolio value decreased from $18.50B to $17.10B this quarter. The number of positions decreased from 58 to 52.
LOW ATHTF FLEX LBTY KMI.WS WBA ENL CVS HPE SHPG NWL LBTYK KMI.PRA KMI LILAB HCA WMB DOW MTOR CAH KMR DXC AET CVB CMCSK IQV ABBV EBAY EBAYL PNR MIK TMUSP WP TMUS BKD UHS CBS.WD CAR VER CNDT GOOGL LILAK RLGY ABBV CPV MHK ESRX TLRD ENDP LH FB DNB PAH TMO CCV MCK KDNUU CCZ GOOG DLPH AGN CCE AAPL MON CI ARMK CBS CSC CBS.A LYB CMCSA FTI.WI FMC LBTYB LBTYA FDX ANTM HUM DWDP KND ABC V CCV.CL FDC LALWF THC KMRFZ HTZ APTV ANTX LILA
This article is part of a series that provides an ongoing analysis of the changes made to John Paulson's 13F stock portfolio on a quarterly basis. It is based on Paulson's regulatory 13F Form filed on 05/15/2018. Please visit our Tracking John Paulson's Paulson & Co. Portfolio series to get an idea of his investment philosophy and our previous update for the fund's moves during Q4 2017.
SNI BGX DISCB VST DISCA TSU TWX AU DISCK ENL BGLF STAY SHPG VIAB HAWK AABA DST OSG.WI SSNC AEM INSW AGG SYMX AET DISC FOX TMUSP TMUS RGORF VRX BKD UTX GOLD BX 2840 TWC OGISD NSW OGSRW MDT BGB SGYP SES CZR OGSWW OGISZ XLGLF SCMP QCOM INSW.WI FOXA OGSBW ENDP NMRK NXPI XL CTL RRS GLD AULGF OSG VRX MYL AGN ODP EGN MON SGYPW HZNP OSGB DISH OVSPW CACQ COL GOLD OVSPA VST.WSA OAS T OVSPD VSTE MNK THM
Document UNITED STATES
The following slide deck was published by Brookdale Senior Living Inc. in conjunction with their 2018 Q1 earnings call.
The first-quarter earnings season has crossed the halfway mark, with results from 343 members from the elite S&P 500 index on board. Per the latest Earnings Trends, performances of these index participants indicate a 24% increase in total earnings on 9.5% higher revenues. The beat ratio is impressive with 78.4% companies surpassing bottom-line expectations and 75.8% outperforming on the top line.
AUY YRI BKD AMED LVS PINC
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to BKD / Brookdale Senior Living, Inc. on message board site Silicon Investor.
|Brookdale Senior Living|
as of ET